Comparative evaluation of the antimicrobial activity of different antimicrobial peptides against a range of pathogenic Bacteria

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  Ebbensgaard, Anna ^a   Mordhorst, Hanne ^a   Overgaard, Michael Toft ^b   Nielsen, Claus Gyrup ^b   Aarestrup, Frank Møller ^a   Hansen, Egon Bech ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b AALBORG UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINYLARGINYLTRYPTOPHYLLYSYLISOLEUCYLVALYLVALYLISOLEUCYLARGINYLTRYPTOPHYLARGINYLARGININE; ARGINYLLEUCYLALANYLARGINYLISOLEUCYLVALYLVALYLISOLEUCYLARGINYLVALYLALANYLARGININE; GLYCYLASPARAGINYLASPARAGINYLARGINYLPROLYLVALYLTYROSYLISOLEUCYLPROLYLGLUTAMINYLPROLYLARGINYLPROLYLPROLYLHISTIDINYLPROLYLARGINYLISOLEUCINE; GLYCYLISOLEUCYLHISTIDINYLASPARTYLISOLEUCYLLEUCYLLYSYLTYROSYLGLYCYLLYSYLPROLYLSERINE; INDOLICIDIN; LIPOPOLYSACCHARIDE; LYSYLLEUCYLARGINYLLYSYLLEUCYLPHENYLALANYLARGINYLLYSYLLEUCYLLEUCYLLYSYLLEUCYLISOLEUCYLARGINYLLYSYLLEUCYLLEUCYLARGININE; LYSYLTRYPTOPHYLLYSYLVALYLPHENYLALANYLLYSYLLYSYLISOLEUCYLGLUTAMYLLYSYLMETHIONYLGLYCYLARGINYLASPARAGINYLISOLEUCYLARGINYLASPARAGINYLGLYCYLISOLEUCYLVALYLLYSYLALANYLGLYCYLPROLYLALANYLISOLEUCYLALANYLVALYLLEUCYLGLYCYLGLUTAMYLALANYLLYSYLALANYLLEUCYLGLYCINE; MELITTIN; POLYPEPTIDE ANTIBIOTIC AGENT; SERYLTRYPTOPHYLLEUCYLSERYLLYSYLTHREONYLALANYLLYSYLLYSYLLEUCYLGLUTAMYLASPARAGINYLSERYLALANYLLYSYLLYSYLARGINYLISOLEUCYLSERYLGLUTAMYLGLCYLISOLEUCYLALANYLISOLEUCYLALANYLISOLEUCYLGLUTAMINYLGLYCYLGLYCYLPROLYLARGININE; UNCLASSIFIED DRUG; VALYLASPARTYLLYSYLGLYCYLSERYLTYROSYLLEUCYLPROLYLARGINYLPROLYLTHREONYLPROLYLPROLYLARGINYLPROLYLISOLEUCYLTYROSYLASPARAGINYLARGINYLASPARAGINE; VALYLASPARTYLLYSYLPROLYLASPARTYLTYROSYLARGINYLPROLYLARGINYLPROLYLARGINYLPROLYLPROLYLASPARAGINYLMETHIONINE; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; PEPTIDE HYDROLASE;

AEROMONAS SALMONICIDA; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CAMPYLOBACTER JEJUNI; CONTROLLED STUDY; CYTOTOXICITY; DRUG DETERMINATION; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FLAVOBACTERIUM; FLAVOBACTERIUM PSYCHROPHILUM; HEMOLYSIS ASSAY; IN VITRO STUDY; LISTERIA MONOCYTOGENES; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTEIN DEGRADATION; PSEUDOMONAS AERUGINOSA; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; STAPHYLOCOCCUS AUREUS; YERSINIA RUCKERI; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECTS; ERYTHROCYTE; GENETICS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEMOLYSIS; HORSE; METABOLISM; MICROBIAL SENSITIVITY TEST; MOLECULAR GENETICS; MULTIDRUG RESISTANCE; MUTATION; PATHOGENICITY; PROTEIN STABILITY; STRUCTURE ACTIVITY RELATION; TEMPERATURE;

AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ERYTHROCYTES; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HEMOLYSIS; HORSES; LIPOPOLYSACCHARIDES; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; PEPTIDE HYDROLASES; PROTEIN STABILITY; PROTEOLYSIS; STRUCTURE-ACTIVITY RELATIONSHIP; TEMPERATURE;

EID: 84957108704     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0144611     Document Type: Article

References (66)

1. Aarestrup FM, Wegener HC, Collignon P. Resistance in bacteria of the food chain: epidemiology and control strategies. Expert Rev Anti Infect Ther. 2008; 6: 733-750. doi: 10.1586/14787210.6.5.733
2. Collignon P, Powers JH, Chiller TM, Aidara-Kane A, Aarestrup FM. World Health Organization ranking of antimicrobials according to their importance in human medicine: A critical step for developing risk management strategies for the use of antimicrobials in food production animals. Clin Infect Dis. 2009; 49: 132-141. doi: 10.1086/599374
3. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 2002; 415: 389-395. doi: 10.1038/415389a
4. Maróti G, Kereszt A, Kondorosi E, Mergaert P. Natural roles of antimicrobial peptides in microbes, plants and animals. Res Microbiol. 2011; 162: 363-374. doi: 10.1016/j.resmic.2011.02.005
5. Hancock REW, Brown KL, Mookherjee N. Host defence peptides from invertebrates-emerging antimicrobial strategies. Immunobiology. 2006; 211: 315-322. doi: 10.1016/j.imbio.2005.10.017
6. Hancock REW, Lehrer R. Cationic peptides: A new source of antibiotics. Trends in Biotechnology. 1998. pp. 82-88. doi: 10.1016/S0167-7799(97)01156-6
7. Delves-Broughton J, Blackburn P, Evans RJ, Hugenholtz J. Applications of the bacteriocin, nisin. Antonie Van Leeuwenhoek. 1996; 69: 193-202.
8. Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol. 2005; 3: 238-250. doi: 10.1038/nrmicro1098
9. Hagiwara A, Imai N, Nakashima H, Toda Y, Kawabe M, Furukawa F, et al. A 90-day oral toxicity study of nisin A, an anti-microbial peptide derived from Lactococcus lactis subsp. lactis, in F344 rats. Food Chem Toxicol. Elsevier Ltd; 2010; 48: 2421-2428. doi: 10.1016/j.fct.2010.06.002
10. Tiwari BK, Valdramidis VP, O' Donnell CP, Muthukumarappan K, Bourke P, Cullen PJ, et al. Application of natural antimicrobials for food preservation. J Agric Food Chem. 2009; 57: 5987-6000. doi: 10.1021/jf900668n
11. Weinberg ED. Antibiotic properties and applications of lactoferrin. Curr Pharm Des. 2007; 13: 801-811. doi: 10.2174/138161207780363095
12. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A. 2000; 97: 6640-6645. doi: 10.1073/pnas.120163297
13. Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, et al. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: The Keio collection. Mol Syst Biol. 2006; 2: 2006.0008. doi: 10. 1038/msb4100050
14. Michel C, Antonio D, Hedrick RP. Production of viable cultures of Flavobacterium psychrophilum: Approach and control. Res Microbiol. 1999; 150: 351-358. Available: http://www.ncbi.nlm.nih.gov/pubmed/10422696.
15. Wikler MA, Cockerill FR, Bush K, Dudley MN, Eliopoulos GM, Hardy DJ, et al. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-eighth edition. Clinical and Laboratory Standards Institute. 2009.
16. Habermann E. Bee and Wasp Venoms. Sci. 1972; 177: 314-322. doi: 10.1126/science.177.4046.314
17. Selsted ME, Novotny MJ, Morris WL, Tang YQ, Smith W, Cullor JS. Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils. J Biol Chem. 1992; 267: 4292-4295.
18. Casteels P, Ampe C, Jacobs F, Vaeck M, Tempst P. Apidaecins: Antibacterial peptides from honeybees. EMBO J. 1989; 8: 2387-2391.
19. Chernysh S, Cociancich S, Briand J-P, Hetru C, Bulet P. The inducible antibacterial peptides of the Hemipteran insect Palomena prasina: Identification of a unique family of prolinerich peptides and of a novel insect defensin. Journal of Insect Physiology. 1996. pp. 81-89. doi: 10.1016/0022-1910(95) 00085-2
20. Cudic M, Condie B a, Weiner DJ, Lysenko ES, Xiang ZQ, Insug O, et al. Development of novel antibacterial peptides that kill resistant isolates. Peptides. 2002; 23: 2071-2083. Available: http://www.ncbi. nlm.nih.gov/pubmed/12535685.
21. Okuda D, Yomogida S, Kuwahara-Arai K. Augmentation of the antimicrobial activities of guinea pig cathelicidin CAP11-derived peptides by amino acid substitutions. Int J Mol Med. 2009; 501-508. doi: 10.3892/ijmm
22. Nagaoka I, Hirota S, Niyonsaba F, Hirata M, Adachi Y, Tamura H, et al. Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-Alpha by blocking the binding of LPS to CD14(+) cells. J Immunol. 2001; 167: 3329-3338.
23. Larrick JW, Hirata M, Balint RF, Lee J, Zhong J, Wright SC. Human CAP18: A novel antimicrobial lipopolysaccharide-binding protein. Infect Immun. 1995; 63: 1291-1297.
24. Falla TJ, Nedra Karunaratne D, Hancock REW. Mode of action of the antimicrobial peptide indolicidin. J Biol Chem. 1996; 271: 19298-19303. doi: 10.1074/jbc.271.32.19298
25. Bhunia A, Domadia PN, Bhattacharjya S. Structural and thermodynamic analyses of the interaction between melittin and lipopolysaccharide. Biochim Biophys Acta-Biomembr. 2007; 1768: 3282-3291. doi: 10.1016/j.bbamem.2007.07.017
26. Gutsmann T, Hagge SO, Larrick JW, Seydel U, Wiese a. Interaction of CAP18-derived peptides with membranes made from endotoxins or phospholipids. Biophys J. Elsevier; 2001; 80: 2935-2945. doi: 10.1016/S0006-3495(01)76259-5
27. Larrick JW, Hirata M, Shimomoura Y, Yoshida M, Zheng H, Zhong J, et al. Antimicrobial activity of rabbit CAP18-derived peptides. Antimicrob Agents Chemother. 1993; 37: 2534-2539. doi: 10.1128/AAC.37. 12.2534
28. Mason DJ, Dybowski R, Larrick JW, Gant VA. Antimicrobial Action of Rabbit Leukocyte CAP18. Antimicrob Agents Chemother. 1997; 41: 624-629.
29. Nagaoka I, Hirota S, Yomogida S, Ohwada A, Hirata M. Synergistic actions of antibacterial neutrophil defensins and cathelicidins. Inflamm Res. 2000; 49: 73-79. doi: 10.1007/s000110050561
30. Travis SM, Anderson NN, Forsyth WR, Espiritu C, Conway BD, Greenberg EP, et al. Bactericidal activity of mammalian cathelicidin-derived peptides. Infect Immun. 2000; 68: 2748-2755. Available: http://www.ncbi.nlm.nih.gov/pubmed/10768969.
31. Yomogida S, Nagaoka I, Yamashita T. Purification of the 11-And 5-kDa antibacterial polypeptides from guinea pig neutrophils. Arch Biochem Biophys. 1996; 328: 219-226. doi: 10.1006/abbi.1996.0166
32. Boman HG, Agerberth B, Boman A. Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine. Infect Immun. 1993; 61: 2978-84. Available: http://www.ncbi.nlm.nih.gov/pubmed/8514403.
33. Kjuul AK, Böllesbach EE, Espelid S, Dunham R, Jørgensen TÒ, Warr GW, et al. Effects of cecropin peptides on bacteria pathogenic to fish. J Fish Dis. 1999; 22: 387-394. doi: 10.1046/j.1365-2761.1999. 00191.x
34. Lee JY, Boman A, Sun CX, Andersson M, Jörnvall H, Mutt V, et al. Antibacterial peptides from pig intestine: isolation of a mammalian cecropin. Proc Natl Acad Sci U S A. 1989; 86: 9159-62. Available: http://www.ncbi.nlm.nih.gov/pubmed/2512577.
35. Moore a J, Beazley WD, Bibby MC, Devine D a. Antimicrobial activity of cecropins. J Antimicrob Chemother. 1996; 37: 1077-1089. Available: http://www.ncbi.nlm.nih.gov/pubmed/8836811.
36. Hilpert K, Volkmer-Engert R, Walter T, Hancock REW. High-Throughput generation of small antibacterial peptides with improved activity. Nat Biotechnol. 2005; 23: 1008-1012. doi: 10.1038/nbt1113
37. Wu M, Hancock RE. Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide. Antimicrob Agents Chemother. 1999; 43: 1274-6. Available: http://www.ncbi.nlm.nih.gov/pubmed/10223951.
38. Subramanian S, Ross NW, MacKinnon SL. Myxinidin, a novel antimicrobial peptide from the epidermal mucus of hagfish, Myxine glutinosa L. Mar Biotechnol (NY). 2009; 11: 748-757. doi: 10.1007/s10126-009-9189-y
39. Cociancich S, Dupont A, Hegy G, Lanot R, Holder F, Hetru C, et al. Novel inducible antibacterial peptides from a hemipteran insect, the sap-sucking bug Pyrrhocoris apterus. Biochem J. 1994; 300 (Pt 2: 567-575.
40. Lee M-T, Sun T-L, Hung W-C, Huang HW. Process of inducing pores in membranes by melittin. Proc Natl Acad Sci U S A. 2013; 110: 14243-14248. doi: 10.1073/pnas.1307010110
41. Huang JF, Xu YM, Hao DM, Huang YB, Liu Y, Chen YX. Structure-guided de novo design of a-helical antimicrobial peptide with enhanced specificity. Pure Appl Chem. 2010; 82: 243-257. doi: 10.1351/paccon-09-01-12
42. Chen Y, Guarnieri MT, Vasil AI, Vasil ML, Mant CT, Hodges RS. Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides. Antimicrob Agents Chemother. 2007; 51: 1398-1406. doi: 10.1128/AAC.00925-06
43. Jiang Z, Vasil AI, Hale JD, Hancock REW, Vasil ML, Hodges RS. Effects of net charge and the number of positively charged residues on the biological activity of amphipathic α-helical cationic antimicrobial peptides. Biopolymers. 2008; 90: 369-383. doi: 10.1002/bip.20911
44. Huang Y, He L, Li G, Zhai N, Jiang H, Chen Y. Role of helicity of α-helical antimicrobial peptides to improve specificity. Protein Cell. 2014; 5: 631-642. doi: 10.1007/s13238-014-0061-0
45. Knappe D, Henklein P, Hoffmann R, Hilpert K. Easy strategy to protect antimicrobial peptides from fast degradation in serum. Antimicrob Agents Chemother. 2010; 54: 4003-4005. doi: 10.1128/AAC.00300-10
46. Malmsten M, Kasetty G, Pasupuleti M, Alenfall J, Schmidtchen A. Highly Selective End-Tagged Antimicrobial Peptides Derived from PRELP. Neyrolles O, editor. PLoS One. 2011; 6: e16400. doi: 10.1371/journal.pone.0016400
47. Strömstedt AA, Pasupuleti M, Schmidtchen A, Malmsten M. Evaluation of strategies for improving proteolytic resistance of antimicrobial peptides by using variants of EFK17, an internal segment of LL-37. Antimicrob Agents Chemother. 2009; 53: 593-602. doi: 10.1128/AAC.00477-08
48. Giuliani A, Rinaldi AC. Beyond natural antimicrobial peptides: Multimeric peptides and other peptidomimetic approaches. Cellular and Molecular Life Sciences. 2011. pp. 2255-2266. doi: 10.1007/s00018-011-0717-3
49. EFSA. Scientific Opinion of the Panel on Biological Hazards /Microbiological risk assessment in feedingstuffs for food-producing animals. EFSA J. 2008; 1-84. Available: http://www.elika.net/datos/articulos/Archivo297/BIOHAZ-PiensosSalmonella08.pdf.
50. Okelo PO, Wagner DD, Carr LE, Wheaton FW, Douglass LW, Joseph SW. Optimization of extrusion conditions for elimination of mesophilic bacteria during thermal processing of animal feed mash. Anim Feed Sci Technol. 2006; 129: 116-137. doi: 10.1016/j.anifeedsci.2005.12.011
51. Amerah AM, Gilbert C, Simmins PH, Ravindran V. Influence of feed processing on the efficacy of exogenous enzymes in broiler diets. Worlds Poult Sci J. 2011; 67: 29-46. doi: 10.1017/S0043933911000031
52. Lohner K. New strategies for novel antibiotics: Peptides targeting bacterial cell membranes. General Physiology and Biophysics. 2009. pp. 105-116. doi: 10.4149/gpb-2009-02-105
53. Guilhelmelli F, Vilela N, Albuquerque P, Derengowski L da S, Silva-Pereira I, Kyaw CM. Antibiotic development challenges: The various mechanisms of action of antimicrobial peptides and of bacterial resistance. Frontiers in Microbiology. 2013. doi: 10.3389/fmicb.2013.00353
54. Vaara M. Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative enteric bacteria. Antimicrobial Agents and Chemotherapy. 1993. pp. 354-356. doi: 10. 1128/AAC.37.2.354
55. Vaara M, Nurminen M. Outer membrane permeability barrier in Escherichia coli mutants that are defective in the late acyltransferases of lipid A biosynthesis. Antimicrob Agents Chemother. 1999; 43: 1459-1462.
56. Shlaes DM, Shlaes JH, Davies J, Williamson R. Escherichia coli susceptible to glycopeptide antibiotics. Antimicrob Agents Chemother. 1989; 33: 192-197. doi: 10.1128/AAC.33.2.192
57. Yethon JA, Vinogradov E, Perry MB, Whitfield C. Mutation of the lipopolysaccharide core glycosyltransferase encoded by waaG destabilizes the outer membrane of Escherichia coli by interfering with core phosphorylation. J Bacteriol. 2000; 182: 5620-5623. doi: 10.1128/JB.182.19.5620-5623.2000
58. Wulff G, Gram L, Ahrens P, Vogel BF. One group of genetically similar Listeria monocytogenes strains frequently dominates and persists in several fish slaughter-And smokehouses. Appl Environ Microbiol. 2006; 72: 4313-4322. doi: 10.1128/AEM.02288-05
59. Fouz B, Zarza C, Amaro C. First description of non-motile Yersinia ruckeri serovar I strains causing disease in rainbow trout, Oncorhynchus mykiss (Walbaum), cultured in Spain. J Fish Dis. 2006; 29: 339-346. doi: 10.1111/j.1365-2761.2006.00723.x
60. Casteels P, Ampe C, Jacobs F, Vaeck M, Tempst P. antibacterial peptides from. 1989; 8: 2387-2391.
61. Gronow S, Brabetz W, Brade H. Comparative functional characterization in vitro of heptosyltransferase I (WaaC) and II (WaaF) from Escherichia coli. Eur J Biochem. 2000; 267: 6602-6611. doi: 10.1046/j. 1432-1327.2000.01754.x
62. Zamyatina A, Gronow S, Puchberger M, Graziani A, Hofinger A, Kosma P. Efficient chemical synthesis of both anomers of ADP L-glycero-And D-glycero-D-manno-heptopyranose. Carbohydr Res. 2003; 338: 2571-2589. doi: 10.1016/S0008-6215(03)00319-7
63. Valvano MA, Marolda CL, Bittner M, Glaskin-Clay M, Simon TL, Klena JD. The rfaE gene from Escherichia coli encodes a bifunctional protein involved in biosynthesis of the lipopolysaccharide core precursor ADP-L-glycero-D-manno-heptose. J Bacteriol. 2000; 182: 488-497. doi: 10.1128/JB.182.2.488-497.2000
64. McArthur F, Andersson CE, Loutet S, Mowbray SL, Valvano MA. Functional analysis of the glyceromanno-heptose 7-phosphate kinase domain from the bifunctional HldE protein, which is involved in ADP-L-glycero-D-manno-heptose biosynthesis. J Bacteriol. 2005; 187: 5292-5300. doi: 10.1128/JB. 187.15.5292-5300.2005
65. Parker CT, Kloser AW, Schnaitman CA, Stein MA, Gottesman S, Gibson BW. Role of the rfaG and rfaP genes in determining the lipopolysaccharide core structure and cell surface properties of Escherichia coli K-12. J Bacteriol. 1992; 174: 2525-2538.
66. Möller-Loennies S, Lindner B, Brade H. Structural Analysis of Oligosaccharides from Lipopolysaccharide (LPS) of Escherichia coli K12 Strain W3100 Reveals a Link between Inner and Outer Core LPS Biosynthesis. J Biol Chem. 2003; 278: 34090-34101. doi: 10.1074/jbc.M303985200